Our programs are designed for people who have struggled to lose weight with diet and exercise alone and want clinician-guided support, monthly monitoring, and treatment options that may include oral or injectable medications when appropriate
Populations Requiring Caution Personal or family history of medullary thyroid cancer contraindicates use of GLP-1 receptor agonists including Retatrutide
Clinically proven antioxidants for a healthy immune system
The Synergy Focus Area Both What it Addresses The Connection: For both parties, PT-141 acts as a bridge
Its once-weekly injection format ensures consistent control over glucose levels and weight, enhancing treatment adherence and patient convenience
In addition to being one of the most bioavailable forms of carnitine, l-carnitine fumarate provides fumaric acid, leading to a synergistic effect in cellular energy production in the mitochondria